Roles of Langerhans cells in genetic immunization

Journal of Dermatological Science

Volumn 20, Issue 1, 1999, Pages 39-52

  Morita, Akimichi ^a   Takashima, Akira ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Genetic immunization; Langerhans cells

Indexed keywords

B7 ANTIGEN; BETA GALACTOSIDASE; CD4 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DNA ANTIBODY; DNA VACCINE; GLYCOPROTEIN GP 39; GREEN FLUORESCENT PROTEIN; MYELIN BASIC PROTEIN; PLASMID DNA;

ANTIGEN PRESENTING CELL; DENDRITIC CELL; DNA TRANSCRIPTION; GENE TARGETING; HUMAN; IMMUNIZATION; INOCULATION; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; LANGERHANS CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIGENS; HUMANS; LANGERHANS CELLS; VACCINES, DNA;

EID: 0032940463     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(98)00076-0     Document Type: Review

References (145)

1. Steinman R.M. The dendritic cell system and its role in immunogenicity. Ann. Rev. Immunol. 9:1991;271-296.
2. Bhardwaj N. Interactions of viruses with dendritic cells: a double-edged sword. J. Exp. Med. 186:1997;795-799.
3. Johnson L.L., Sayles P.C. Interleukin-12, dendritic cells, and the initiation of host-protective mechanisms against Toxoplasma gondii. J. Exp. Med. 186:1997;1799-1802.
4. Shurin M.R. Dendritic cells presenting tumor antigen. Cancer Immunol. Immunother. 43:1996;158-164.
5. Steinman R.M., Swanson J. The endocytic activity of dendritic cells. J. Exp. Med. 182:1995;283-288.
6. Lanzavecchia A. Mechanisms of antigen uptake for presentation. Curr. Opin. Immunol. 8:1996;348-354.
7. Steinman R.M., Pack M., Inaba K. Dendritic cells in the T-cell areas of lymphoid organs. Immunol. Rev. 156:1997;25-37.
8. Cella M., Sallusto F., Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9:1997;10-16.
9. Caux C., Liu Y.J., Banchereau J. Recent advances in the study of dendritic cells and follicular dendritic cells. Immunol. Today. 16:1995;2-5.
10. Ni K., O'Neill H.C. The role of dendritic cells in T cell activation. Immunol. Cell Biol. 75:1997;223-230.
11. Van Kooten C., Banchereau J. Functions of CD40 on B cells, dendritic cells and other cells. Curr. Opin. Immunol. 9:1997;330-337.
12. Matsue H., Cruz P.D. Jr, Bergstresser P.R., Takashima A. Langerhans cells are the major source of mRNA for IL-1β and MlP-1α among unstimulated mouse epidermal cells. J. Invest. Dermatol. 99:1992;537-541.
13. Schreiber S., Kilgus O., Payer E. et al. Cytokine pattern of Langerhans cells isolated from murine epidermal cell cultures. J. Immunol. 149:1992;3525-3534.
14. Koch F., Stanzl U., Jennewein P. et al. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184:1996;741-746.
15. Cella M., Scheidegger D., Palmer-Lehmann K., Lane P., Lanzavecchia A., Alber G. Ligation of CD40 on dendritic cells taggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:1996;747-752.
16. + T cells. J. Immunol. 154:1995;5071-5079.
17. Caux C., Massacrier C., Vanbervliet B. et al. Activation of human dendritic cells through CD40 crosslinking. J. Exp. Med. 180:1994;1263-1272.
18. Heufler C., Topar G., Koch F. et al. Cytokine gene expression in murine epidermal cell suspensions: interleukin 1β and macrophage inflammatory protein 1α are selectively expressed in Langerhans cells but are differentially regulated in culture. J. Exp. Med. 176:1992;1221-1226.
19. Mohamadzadeh M., Poltorak A.N., Bergstresser P.R., Beutler B., Takashima A. Dendritic cells produce macrophage inflammatory protein-1γ, a new member of the CC chemokine family. J. Immunol. 156:1996;3102-3106.
20. Adema G.J., Hartgers F., Verstraten R. et al. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature. 387:1997;713-717.
21. Tang D., DeVit M., Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature. 356:1992;152-154.
22. Nicoloff B.J., Turka L.A. Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immunol. Today. 15:1994;464-469.
23. + keratinocytes. J. Immunol. 147:1991;4155-4161.
24. Condon C., Watkins S.C., Celluzzi M.C., Thompson K., Falo Jr L.D. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2:1996;1122-1128.
25. Klinman D.M., Sechler J.M., Conover J., Gu M., Rosenberg A.S. Contribution of cells at the site of DNA vaccination to the generation of antigen-specific immunity and memory. J. Immunol. 160:1998;2388-2392.
26. Torres C.A., Iwasaki A., Barber B.H., Robinson H.L. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J. Immunol. 158:1997;4529-4532.
27. Doe B., Selby M., Barnett S., Baenziger J., Walker C.M. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. USA. 93:1996;8578-8583.
28. Casares S., Inaba K., Brumeanu T.D., Steinman R.M., Bona C.A. Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope. J. Exp. Med. 186:1997;1481-1486.
29. + T cells after gene gun immunization. J. Exp. Med. 188:1998;1075-1082.
30. Iwasaki A., Torres C.A., Ohashi P.S., Robinson H.L., Barber B.H. The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J. Immunol. 159:1997;11-14.
31. Corr M., Lee D.J., Carson D.A., Tighe H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 184:1996;1555-1560.
32. Manickan E., Kanangat S., Rouse R.J., Yu Z., Rouse B.T. Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. J. Leukocyte Biol. 61:1997;125-132.
33. Ribas A., Butterfield L.H., McBride W.H. et al. Genetic immunization for the melanoma antigen MART-l/Melan-A using recombinant adenovirus-transduced murine dendritic cells. Cancer Res. 57:1997;2865-2869.
34. Timares L., Takashima A., Johnston S.A. Quantitative analysis of the immunopotency of genetically transfected dendritic cells. Proc. Natl. Acad. Sci. USA. 22:1998;13147-13152.
35. Tuting T., Storkus W.J., Falo L.D. Jr DNA immunization targeting the skin: molecular control of adaptive immunity. J. Invest. Dermatol. 111:1998;183-188.
36. Schuler G., Thurner B., Romani N. Dendritic cells: from ignored cells to major players in T-cell-mediated immunity. Int. Arch. Allergy Immunol. 112:1997;317-322.
37. + T cells. J. Exp. Med. 185:1997;2133-2141.
38. Aiba S., Katz S.I. Phenotypic and functional characteristics of in vivo-activated Langerhans cells. J. Immunol. 145:1990;2791-2796.
39. Aiba S., Nakagawa S., Ozawa H., Miyake K., Tagami H. Up-regulation of α4 integrin on activated Langerhans cells: analysis of adhesion molecules on Langerhans cells relating to their migration from skin to draining lymph nodes. J. Invest. Dermatol. 100:1993;143-147.
40. Enk A.H., Katz S.I. Early molecular events in the induction phase of contact sensitivity. Proc. Natl. Acad. Sci. USA. 89:1992;1398-1402.
41. Kripke M.L., Munn C.G., Jeevan A., Tan J.-M., Bucana C. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J. Immunol. 145:1990;2833-2838.
42. Chattergoon M.A., Robinson T.M., Boyer J.D., Weiner D.B. Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells. J. Immunol. 160:1998;5707-5718.
43. Krieg A.M., Yi A.K., Schorr J., Davis H.L. The role of CpG dinucleotides in DNA vaccines [Review] [39 refs]. Trends Microbiol. 6:1998;23-27.
44. Klinman D.M., Yamshchikov G., Ishigatsubo Y. Contabution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 158:1997;3635-3639.
45. Waisman A., Ruiz P.J., Hirschberg D.L. et al. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity [see comments]. Nat. Med. 2:1996;899-905.
46. Lobell A., Weissert R., Storch M.K. et al. Vaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to Fc of immunoglobulin G suppresses experimental autoimmune encephalomyelitis. J. Exp. Med. 187:1998;1543-1548.
47. Raz E., Tighe H., Sato Y. et al. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc. Natl. Acad. Sci. USA. 93:1996;5141-5145.
48. Hsu C.H., Chua K.Y., Tao M.H. et al. Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization [see comments]. Nat. Med. 2:1996;540-544.
49. + T cells. Int. Arch. Allergy Immunol. 113:1997;227-230.
50. Hsu C.H., Chua K.Y., Tao M.H., Huang S.K., Hsieh K.H. Inhibition of specific IgE response in vivo by allergen-gene transfer. Int. Immunol. 8:1996;1405-1411.
51. Syrengelas A.D., Chen T.T., Levy R. DNA immunization induces protective immunity against B-cell lymphoma. Nat. Med. 2:1996;1038-1041.
52. Davis H.L., Millan C.L., Watkins S.C. Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA. Gene Ther. 4:1997;181-188.
53. Blechynden L.M., Lawson M.A., Tabarias H. et al. Myositis induced by naked DNA immunization with the gene for histidyl-tRNA synthetase. Hum. Gene Ther. 8:1997;1469-1480.
54. Nichols WW, Ledwith BJ, Manam SV, Troilo PJ. Potential DNA vaccine integration into host cell genome. Ann New York Acad Sci 1997;30-39.
55. Mor G., Yamshchikov G., Sedegah M. et al. Induction of neonatal tolerance by plasmid DNA vaccination of mice. J. Clin. Invest. 98:1996;2700-2705.
56. Manickan E., Yu Z., Rouse B.T. DNA immunization of neonates induces immunity despite the presence of maternal antibody. J. Clin. Invest. 100:1997;2371-2375.
57. Hassett D.E., Zhang J., Whitton J.L. Neonatal DNA immunization with a plasmid encoding an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge. J. Virol. 71:1997;7881-7888.
58. Martinez X., Brandt C., Saddallah F. et al. DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life. Proc. Natl. Acad. Sci. USA. 94:1997;8726-8731.
59. + T helper cells that secrete IFN-γ and TNF-α J. Immunol. 158:1997;4471-4477.
60. Boyer J.D., Ugen K.E., Wang B. et al. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination [see comments]. Nat. Med. 3:1997;526-532.
61. MacGregor R.R., Boyer J.D., Ugen K.E. et al. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J. Infect. Dis. 178:1998;92-100.
62. Calarota S., Bratt G., Nordlund S. et al. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancet. 351:1998;1320-1325.
63. Barry M.A., Lai W.C., Johnston S.A. Protection against mycoplasma infection using expression library immunization: a general approach to vaccine development. Nature. 377:1995;632-635.
64. Boyle J.S., Koniaras C., Lew A.M. Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization. Int. Immunol. 9:1997;1897-1906.
65. Wu Y., Kipps T.J. Deoxyribonucleic acid vaccines encoding antigens with rapid proteasomedependent degradation are highly efficient inducers of cytolytic T lymphocytes. J. Immunol. 159:1997;6037-6043.
66. Rodriguez F., Zhang J., Whitton J.L. DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction. J. Virol. 71:1997;8497-8503.
67. Uger R.A., Barber B.H. Creating CTL targets with epitope-linked β2-microglobul in constructs. J. Immunol. 160:1998;1598-1605.
68. Grifantini R., Finco O., Bartolini E. et al. Multi-plasmid DNA vaccination avoids antigenic competition and enhances immunogenicity of a poorly immunogenic plasmid. Eur. J. Immunol. 28:1998;1225-1232.
69. Thomson S.A., Sherritt M.A., Medveczky J. et al. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination. J. Immunol. 160:1998;1717-1723.
70. Andre S., Seed B., Eberle J., Schraut W., Bultmann A., Haas J. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J. Virol. 72:1998;1497-1503.
71. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., Robinson H.L. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA. 90:1993;11478-11482.
72. Boyle J.S., Silva A., Brady J.L., Lew A.M. DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity. Proc. Natl. Acad. Sci. USA. 94:1997;14626-14631.
73. Mitra A.K., Arnott S., Sheehan J.K. Hyaluronic acid: molecular conformation and interactions in the tetragonal form of the potassium salt containing extended chains. J. Mol. Biol. 169:1983;813-827.
74. Pertmer T.M., Roberts T.R., Haynes J.R. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 70:1996;6119-6125.
75. Asakura Y., Hinkula J., Leandersson A.C., Fukushima J., Okuda K., Wahren B. Induction of HIV-1 specific mucosal immune responses by DNA vaccination. Scan. J. Immunol. 46:1997;326-330.
76. Kuldin N., Daheshia M., Karem K., Manickan E., Rouse B.T. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J. Virol. 71:1997;3138-3145.
77. Okada E., Sasaki S., Ishii N. et al. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J. Immunol. 159:1997;3638-3647.
78. Livingston J.B., Lu S., Robinson H., Anderson D.J. Immunization of the female genital tract with a DNA-based vaccine. Infect. Immun. 66:1998;322-329.
79. Chen S.C., Jones D.H., Fynan E.F. et al. Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J. Virol. 72:1998;5757-5761.
80. Dagi A., Guzman C.A., Gerstel B. et al. Oral somatic transgene vaccination using attenuated S. typhimurium. Cell. 91:1997;765-775.
81. Maecker H.T., Umetsu D.T., DeKruyff R.H., Levy S. DNA vaccination with cytokine fusion constructs biases the immune response to ovalbumin. Vaccine. 15:1997;1687-1696.
82. Hakim I., Levy S., Levy R. A nine-amino acid peptide from IL-1β augments antitumor immune responses induced by protein and DNA vaccines. J. Immunol. 157:1996;5503-5511.
83. Horspool J.H., Perrin P.J., Woodcock J.B. et al. Nucleic acid vaccine-induced immune responses require CD28 costimulation and are regulated by CTLA4. J. Immunol. 160:1998;2706-2714.
84. Dietrich G., Bubert A., Gentschev I. et al. Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes [see comments]. Nat. Biotechnol. 16:1998;181-185.
85. Sasaki S., Fukushirna J., Arai H. et al. Human immunodeficiency virus type-1-specific immune responses induced by DNA vaccination are greatly enhanced by mannan-coated diC14-amidine. Eur. J. Immunol. 27:1997;3121-3129.
86. Toda S., Ishii N., Okada E. et al. HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-γ antibody. Immunology. 92:1997;111-117.
87. Boyle J.S., Brady J.L., Lew A.M. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature. 392:1998;408-411.
88. Gonzalez A.J., Morello C.S., Cranmer L.D., Spector D.H. DNA immunization confers protection against murine cytomegalovirus infection. J. Virol. 70:1996;7921-7928.
89. Vanderzanden L., Bray M., Fuller D. et al. DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge. Virology. 246:1998;134-144.
90. Xu L., Sanchez A., Yang Z. et al. Immunization for Ebola virus infection [see comments]. Nat. Med. 4:1998;37-42.
91. Konishi E., Yamaoka M., Khin S.W., Kurane I., Mason P.W. Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes. J. Virol. 72:1998;4925-4930.
92. Schrnaliohn C., Vanderzanden L., Bray M. et al. Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge. J. Virol. 71:1997;9563-9569.
93. Chinsangaram J., Beard C., Mason P.W., Zellner M.K., Ward G., Grubman M.J. Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins. J. Virol. 72:1998;4454-4457.
94. Ward G., Rieder E., Mason P.W. Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine. J. Virol. 71:1997;7442-7447.
95. Chow Y.H., Huang W.L., Chi W.K., Chu Y.D., Tao M.H. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J. Virol. 71:1997;169-178.
96. Geissler M., Schirmbeck R., Reimann J., Blum H.E., Wands J.R. Cytokine and hepatitis B virus DNA co-immunizations enhance cellular and humoral immune responses to the middle but not to the large hepatitis B virus surface antigen in mice. Hepatology. 28:1998;202-210.
97. Geissler M., Gesien A., Wands J.R. Inhibitory effects of chronic ethanol consumption on cellular immune responses to hepatitis C virus core protein are reversed by genetic immunizations augmented with cytokine-expressing plasmids. J. Immunol. 159:1997;5107-5113.
98. Davis H.L., McCluskie M.J., Gerin J.L., Purcell R.H. DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proc. Natl. Acad. Sci. USA. 93:1996;7213-7218.
99. Lagging L.M., Meyer K., Hoft D., Houghton M., Belshe R.B., Ray R. Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J. Virol. 69:1995;5859-5863.
100. McClements W.L., Armstrong M.E., Keys R.D., Liu M.A. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc. Natl. Acad. Sci. USA. 93:1996;11414-11420.
101. + T lymphocytes. J. Immunol. 155:1995;259-265.
102. Tsuji T., Hamajirna K., Ishii N. et al. Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1 specific cell-mediated immunity induced by a plasmid encoding the viral antigen. Eur. J. Immunol. 27:1997;782-787.
103. Kim J.J., Ayyavoo V., Bagarazzi M.L. et al. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 158:1997;816-826.
104. Svanholm C., Lowenadler B., Wigzell H. Amplification of T-cell and antibody responses in DNA-based immunization with HIV-1 Nef by co-injection with a GM-CSF expression vector. Scan. J. Immunol. 46:1997;298-303.
105. Kim J.J., Bagarazzi M.L., Trivedi N. et al. Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes. Nat. Biotechnol. 15:1997;641-646.
106. Fuller D.H., Haynes J.R. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine. AIDS Res. Hum. Retroviruses. 10:1994;1433-1441.
107. Robinson H.L., Boyle C.A., Feltquate D.M., Morin M.J., Santoro J.C., Webster R.G. DNA immunization for influenza virus: studies using hemagglutinin- and nucleoprotein-expressing DNAs. J. Infect. Dis. 176(Suppl 1):1997;S50-S55.
108. Iwasaki A., Stiernholm B.J., Chan A.K., Berinstein N.L., Barber B.H. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J. Immunol. 158:1997;4591-4601.
109. Donnelly J.J., Friedman A., Martinez D. et al. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus [see comments]. Nat. Med. 1:1995;583-587.
110. Ulmer J.B., Deck R.R., DeWitt C.M., Friedman A., Donnelly J.J., Liu M.A. Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine. 12:1994;1541-1544.
111. Webster R.G., Fynan E.F., Santoro J.C., Robinson H. Protection of ferrets against influenza challenge with a DNA vaccine to the hemagglutinin. Vaccine. 12:1994;1495-1498.
112. Yang K., Mustafa F., Valsamakis A., Santoro J.C., Griffin D.E., Robinson H.L. Early studies on DNA-based immunizations for measles virus. Vaccine. 15:1997;888-891.
113. Sundaram P., Tigelaar R.E., Xiao W., Brandsma J.L. Intracutaneous vaccination of rabbits with the E6 gene of cottontail rabbit papillomavirus provides partial protection against virus challenge. Vaccine. 16:1998;613-623.
114. LodmeU D.L., Ray N.B., Parnell M.J. et al. DNA immunization protects nonhuman primates against rabies virus. Nat. Med. 4:1998;949-952.
115. Garmendia A.K., Chang S., Tulman E.R., Rompato G., Bu J. Immunogenicity of vector DNA vaccine constructs of pseudorabies virus immediate early gene (IE180) in mice and swine. Ann. New York Acad. Sci. 849:1998;485-489.
116. Herrmann J.E., Chen S.C., Fynan E.F. et al. Protection against rotavirus infections by DNA vaccination. J. Infect. Dis. 174(Suppl 1):1996;S93-S97.
117. Alves A.M., Lasaro M.O., Almeida D.F., Ferreira L.C. Epitope specificity of antibodies raised against enterotoxigenic Escherichia cold CFA/I fimbriae in mice immunized with naked DNA. Vaccine. 16:1998;9-15.
118. Zhu X., Venkataprasad N., Thangaraj H.S. et al. Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. J. Immunol. 158:1997;5921-5926.
119. Lai W.C., Pakes S.P., Ren E.C., Lu Y.S., Bennett M. Therapeutic effect of DNA immunization of genetically susceptible mice infected with virulent Mycoplasma pulmonis. J. Immunol. 158:1997;2513-2516.
120. McDaniel L.S., Loechel F., Benedict C. et al. Immunization with a plasmid expressing pneumococcal surface protein A (PspA) can elicit protection against fatal infection with Streptococcus pneumoniae. Gene Ther. 4:1997;375-377.
121. Zhang D., Yang X., Berry J., Shen C., McClarty G., Brunham R.C. DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection. J. Infect. Dis. 176:1997;1035-1040.
122. Sjolander A., Baldwin T.M., Curtis J.M., Handman E. Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to leishmaniasis. J. Immunol. 160:1998;3949-3957.
123. Gurunathan S., Sacks D.L., Brown D.R. et al. Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. J. Exp. Med. 186:1997;1137-1147.
124. Sedegah M., Jones T.R., Kaur M. et al. Boosting with recombinant vaccinia increases immunogenicity and protective efflcacy of malaria DNA vaccine. Proc. Natl. Acad. Sci. USA. 95:1998;7648-7653.
125. + T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ardcara. Nat. Med. 4:1998;397-402.
126. Leitner W.W., Seguin M.C., Ballou W.R. et al. Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites. J. Immunol. 159:1997;6112-6119.
127. Gramzinski R.A., Maris D.C., Doolan D. et al. Malaria DNA vaccines in Aotus monkeys. Vaccine. 15:1997;913-915.
128. + cell-, interferon γ-, and nitric oxide-dependent immunity. J. Exp. Med. 183:1996;1739-1746.
129. Sedegah M., Hedstrom R., Hobart P., Hoffman S.L. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA. 91:1994;9866-9870.
130. Kayes S.G., Shaneyfelt R.C., Monteiro C., O'Brien J.J. Overproduction of SM28GST in a baculovirus expression vector and its use to evaluate the in vivo immune responses of mice vaccinated against Schistosoma mansoni with naked DNA encoding the SM28GST gene. J. Parasitol. 84:1998;764-770.
131. Alberti E., Acosta A., Sarmiento M.E. et al. Specific cellular and humoral immune response in Balb/c mice immunized with an expression genomic library of Trypanosoma cruzi. Vaccine. 16:1998;608-612.
132. Caspar C.B., Levy S., Levy R. Idiotype vaccines for non-Hodgkin's lymphoma induce polyclonal immune responses that cover mutated tumor idiotypes: comparison of different vaccine formulations. Blood. 90:1997;3699-3706.
133. Spellerberg M.B., Zhu D., Thompsett A., King C.A., Hamblin T.J., Stevenson F.K. DNA vaccines against lymphoma: promotion of anti-idiotypic antibody responses induced by single chain Fv genes by fusion to tetanus toxin fragment C. J. Immunol. 159:1997;1885-1892.
134. Irvine K.R., Rao J.B., Rosenberg S.A., Restifo N.P. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. J. Immunol. 156:1996;238-245.
135. Chen Y., Hu D., Eling D.J., Robbins J., Kipps T.J. DNA vaccines encoding full-length or truncated Neu induce protective immunity against Neu-expressing mammary tumors. Cancer Res. 58:1998;1965-1971.
136. Rosato A., Zambon A., Milan G. et al. CTL response and protection against P815 tumor challenge in mice immunized with DNA expressing the tumor-specific antigen P815A. Hum. Gene Ther. 8:1997;1451-1458.
137. Geissler M., Wands G., Gesien A., de la Monte S., Bellet D., Wands J.R. Genetic immunization with the free human chorionic gonadotropin β subunit elicits cytotoxic T lymphocyte responses and protects against tumor formation in mice. Lab. Invest. 76:1997;859-871.
138. Schirmbeck R., Bohm W., Reimann J. DNA vaccination primes MHC class I-restricted, simian virus 40 large tumor antigen-specific CTL in H-2d mice that reject syngeneic tumors. J. Immunol. 157:1996;3550-3558.
139. Ciernik I.F., Berzofsky J.A., Carbone D.P. Induction of cytotoxic T lymphocytes and antitumor immunity with DNA vaccines expressing single T cell epitopes. J. Immunol. 156:1996;2369-2375.
140. Kim J.J., Trivedi N.N., Nottingham L.K. et al. Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Eur. J. Immunol. 28:1998;1089-1103.
141. Chow Y.H., Chiang B.L., Lee Y.L. et al. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J. Immunol. 160:1998;1320-1329.
142. Larsen D.L., Dybdahl-Sissoko N., McGregor M.W. et al. Coadministration of DNA encoding interleukin-6 and hernagglutinin confers protection from influenza virus challenge in mice. J. Virol. 72:1998;1704-1708.
143. Xiang Z.Q., He Z., Wang Y., Ertl H.C. The effect of interferon-γ on genetic immunization. Vaccine. 15:1997;896-898.
144. Corr M., Tighe H., Lee D. et al. Costimulation provided by DNA immunization enhances antitumor immunity. J. Immunol. 159:1997;4999-5004.
145. Mendoza R.B., CantweU M.J., Kripps T.J. Immunostimulatory effects of a plasmid expressing CD40 Ligand (CD154) on gene immunization. J. Immunol. 159:1997;5777-5781.